Goodwin
Danielle Fong
- Deals
- 5
- Latest
- May 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 5 deals
Often works with
- Arman Oruc 3 deals together
- Artimus Cunningham 2 deals together
- Samantha Mita 2 deals together
- Ai Tajima 2 deals together
- Sarah Solomon 2 deals together
- Bonnee Nie 2 deals together
- Sarah Bock 2 deals together
- James Devendorf 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| May 2026 | LimmaTech Biologics AG | – | Eli Lilly and Company | Acquisition | Legal adviser to LimmaTech Biologics AG (target) | Pending | 780.0 | Biotech | Eli Lilly and Company acquisition of LimmaTech Biologics AG |
| Apr 2026 | Kelonia Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Kelonia Therapeutics (target) | Announced | 7,000.0 | Biotech+2 | Eli Lilly and Company acquisition of Kelonia Therapeutics |
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
| Apr 2026 | Document Crunch | – | Trimble | Acquisition | Legal adviser to Document Crunch (target) | Announced | – | Vertical SaaS+2 | Trimble acquisition of Document Crunch |
| Jan 2026 | XConn | – | Marvell | Acquisition | Legal adviser to XConn Technologies (target) | Completed | 540.0 | Hardware & Semiconductors | Marvell acquisition of XConn |
Deals where Danielle Fong is named on the firm's deal team, by the firm or the press.